GILEAD SCIENCES, INC

GILD

Real-time Estimate - 11/24 04:03:15 pm
60.3USD	+0.68%

Prev.	59.8900
Open	59.6300
High	60.9800
Low	59.5900
Volume	8 693 719

7h ago	Gilead Sciences : to Present at the 3rd Annual Evercore ISI HealthCONx...
21h ago	Gilead Sciences : to Present at the 3rd Annual Evercore ISI HealthCONx...
1d ago	Canada could approve COVID-19 vaccines early next year -regulator
1d ago	Gilead Sciences : U.S. infectious disease group backs Gilead's remdesivir...

	Short Term	Mid-Term	Long Term
Trend	Bullish	Bearish	Bearish
Resistance	61,1	66,3	69,4
Spread/Res.	-1,2%	-9,0%	-13%
Spread/Supp.	0,80%	3,8%	3,8%
Support	59,9	58,2	58,2

Sales 2020	23 650 M - -
Net income 2020	34,3 M - -
Net Debt 2020	20 525 M - -
P/E ratio 2020	-4 394x
Yield 2020	4,55%

Capitalization	75 074 M 75 074 M -
EV / Sales 2020	4,04x
EV / Sales 2021	3,85x
Nbr of Employees	11 800
Free-Float	99,6%

Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows:
- sale of drugs (98.5%): for the treatment of HIV, hepatitis B virus and hepatitis C virus (93.4% of net sales) and other (6.6%; primarily...

>> Read more

Sector :

Bio Therapeutic Drugs

Calendar :

2020-12-05 Presentation

Trading Rating :

Investor Rating :

Mean consensus	OUTPERFORM
Number of Analysts	30
Average target price	73,52 $
Last Close Price	59,89 $
Spread / Highest target	75,3%
Spread / Average Target	22,8%
Spread / Lowest Target	-3,16%